“Simplicity has been a major driver for SleepView market demand. The single-ended belt and direct connection to the SleepView make placing the system very easy for patients.”rip-belt-disposable_cpoj-3n

CleveMed, Cleveland, OH – Nov. 22, 2016 – CleveMed, a leading provider of home sleep apnea testing (HSAT) solutions was issued another important patent (9,492,105) for its flagship product: SleepView® Monitor. The patent is titled “Device for sleep diagnosis”, which covers one of the key SleepView sensors used by patients at home.  “We are very excited about this patent because it covers our proprietary respiratory effort attachment methodology, which dramatically simplifies device use in the home. Simplicity has been a major driver for SleepView market demand”, said Sarah Weimer, Director of Sleep Products and Services. “The single-ended belt and direct connection to the SleepView make placing the system very easy for patients.”

“With this new patent, CleveMed’s issued patents in the area of sleep disorders monitoring grows to over 25 with 20 more patents that are pending. We are proud of our intellectual property strength; our patents cover innovative methods in many areas that are already playing critical roles in the market such as simplified home testing and therapy monitoring among others,” said Hani Kayyali, CleveMed president and an inventor on the patent.

Obstructive sleep apnea (OSA), the most prevalent form of sleep apnea, is a repeated interruption of normal breathing during sleep due to a collapse of the upper airway. It is estimated to impact as many people as asthma and diabetes; yet, up to 80 percent of the population with the disease remain undiagnosed and untreated. Moreover, OSA leads to serious health and economic consequences. Numerous studies link OSA to major chronic diseases such as stroke, heart failure, diabetes, obesity, hypertension and increased odds of serious car crash injuries.

CleveMed is a fast growing company with a wide range of sleep testing services and cloud based technologies that allow sleep disorders to be monitored in the home, including Sapphire PSG, SleepScout, SleepView®, SleepViewSM Web-portal, and SleepView Direct. CleveMed’s goal is to expand the reach of sleep medicine with technologies that speed diagnosis for providers, reduce healthcare costs for payers, and most importantly improve patients’ experiences in the home. For more information, please visit www.CleveMed.com (Follow us on twitter, youtube, LinkedIn, and facebook).  SleepView is a registered trademark and a service mark, and Sapphire PSG and SleepScout are trademarks of Cleveland Medical Devices Inc. of Cleveland, OH.